BioJiva
Phase 1BioJiva is a clinical stage pharmaceutical company pioneering the development of first-in-class therapeutics to treat degenerative diseases resulting from Lipid peroxidation (LPO). BioJiva has developed a series of oxidation resistant armored Polyunsaturated Fatty Acids (PUFAs) as drug interventions to mitigate LPO.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
BioJiva is a clinical stage pharmaceutical company pioneering the development of first-in-class therapeutics to treat degenerative diseases resulting from Lipid peroxidation (LPO). BioJiva has developed a series of oxidation resistant armored Polyunsaturated Fatty Acids (PUFAs) as drug interventions to mitigate LPO.